The AlleyWatch April 2026 New York Venture Capital Funding Report – AlleyWatch

Funding by Stage — NYC

Stage
Capital Deployed
Deal Count
Avg Deal Size
% of Total Capital

Early-Stage
$136.2M
28
$4.9M
7.6%

Series A
$394.7M
21
$18.8M
22.1%

Series B
$351.4M
9
$39.0M
19.7%

Late-Stage
$905.3M
7
$129.3M
50.6%

Total
$1.79B
65
$27.5M
100%

Top 10 NYC Venture Capital Deals — April 2026

#
Company
Amount
Stage
Sector

1
VAST Data
$500M
Late-Stage
AI Infrastructure, Database, Software

2
Rogo
$160M
Late-Stage
Artificial Intelligence, Financial Services, FinTech

3
Avoca
$125M
Series B
Artificial Intelligence, Business Process Automation

4
Chapter
$100M
Late-Stage
Health Care, Health Insurance, Medicare

5
Kashable
$60M
Late-Stage
Consumer Finance, Employee Benefits, FinTech

6
Manifest OS
$60M
Series A
Artificial Intelligence, Legal Technology

7
Artemis
$55M
Series A
Artificial Intelligence, Cybersecurity

8
Courier Health
$50M
Series B
CRM, Health Care, Life Sciences, Software

9
Actively
$45M
Series B
Artificial Intelligence, Marketing Automation, Sales Automation

10
Versana
$43M
Late-Stage
Data Integration, Finance, FinTech

VAST Data Leads a Strong Month for AI Infrastructure

April 2026’s largest transaction was VAST Data, the NYC-based AI infrastructure company, which raised a $500 million late-stage equity round. VAST Data’s platform integrates storage, database, and compute capabilities into a unified AI operating system, making it a foundational player in the infrastructure stack that increasingly underpins enterprise AI deployments. The raise underscores how investors are placing large, concentrated bets on the picks-and-shovels layer of the AI economy.

Excluding VAST Data, the remaining 64 deals totaled $1.29 billion — a figure that, on its own, would represent a healthy month for the ecosystem. The AI theme extended well beyond a single deal: Rogo raised $160 million for its AI platform serving investment banks and financial institutions, while Avoca secured $125 million in a Series B for its AI agents handling customer interactions. Manifest OS, building AI-native law firms, raised $60 million in a Series A, and cybersecurity AI company Artemis closed a $55 million Series A. Altogether, AI companies captured 66.7% of all NYC venture capital deployed in April — $1.19 billion across 33 deals.

Late-Stage Capital Leads; Series A and B Show Balanced Depth

Late-stage rounds commanded 50.6% of all capital deployed in April, with 7 deals accounting for $905.3 million. Beyond VAST Data, the late-stage cohort included Chapter ($100M for its Medicare navigation platform), Rogo ($160M), Kashable ($60M for employer-sponsored fintech), and Versana ($43M for loan market infrastructure) — a diverse set of sectors reflecting the maturity of NYC’s later-stage pipeline.

Series A activity was robust, with 21 deals totaling $394.7 million and an average round size of $18.8 million. Series B produced 9 deals worth $351.4 million, led by Avoca ($125M), Courier Health ($50M), and Actively ($45M). Together, Series A and B rounds represented 41.8% of total capital and 46.2% of deal count — indicating a healthy mid-stage pipeline beneath the late-stage headline. Early-stage activity was the most active by deal count, with 28 deals totaling $136.2 million at an average of $4.9 million per deal.

Healthcare and Fintech Round Out the Ecosystem

While AI dominated the capital headlines, healthcare and fintech companies demonstrated steady investor appetite outside the AI theme. Chapter raised $100 million in a late-stage round for its Medicare advisory platform helping seniors navigate health coverage — a sector benefiting from long-term demographic tailwinds. Courier Health closed a $50 million Series B for its patient relationship management platform serving the life sciences and biopharma sectors. Kashable raised $60 million for its employer-sponsored lending and financial wellness platform, while Versana secured $43 million to expand its loan market infrastructure services. These rounds highlight that NYC’s venture ecosystem remains diverse, even as AI commands a significant share of the capital deployed.

NYC vs. US National Venture Capital — April 2026

Stage
NYC Capital
NYC Deals
NYC % of Total
US Capital
US Deals
US % of Total

Early-Stage
$136.2M
28
7.6%
$1.13B
254
5.4%

Series A
$394.7M
21
22.1%
$1.96B
98
9.4%

Series B
$351.4M
9
19.7%
$1.83B
40
8.8%

Late-Stage
$905.3M
7
50.6%
$15.89B
50
76.4%

Total
$1.79B
65
100%
$20.80B
442
100%

Nationally, US venture capital activity totaled $20.80 billion across 442 deals in April 2026. New York City accounted for 8.6% of US venture capital deployed and 14.7% of national deal volume. The US market’s late-stage concentration was more pronounced at the national level — 76.4% of capital went to late-stage deals, driven in part by Project Prometheus’s $10 billion raise. AI companies across the country captured 73.0% of all US venture capital, compared to NYC’s 66.7% AI capital share, reflecting strong AI investment momentum nationally while NYC’s ecosystem showed notable breadth across non-AI sectors as well.

Looking Ahead

April’s results demonstrate continued momentum in New York’s venture ecosystem, with capital growth of 27.7% year-over-year on largely stable deal volume — a sign of expanding round sizes rather than a broader surge in activity. The healthy spread of investment across Series A and B stages alongside late-stage activity suggests a well-functioning pipeline. As AI investment matures and enterprise adoption deepens, infrastructure and tooling companies are increasingly commanding institutional-scale commitments, as VAST Data’s raise illustrates. Whether May sustains this pace will depend on macroeconomic conditions and whether another large-scale AI round emerges from the city’s growing roster of well-funded startups.

Methodology

Data for this report is sourced from AlleyWatch proprietary funding data (funding.alleywatch.com) and covers venture capital rounds announced or closed in April 2026 by NYC-headquartered startups. Deals are classified into four stages: Early-Stage (pre-seed, seed, angel, accelerator, and incubator rounds); Series A; Series B; and Late-Stage (Series C and beyond). AI company classification is based on the presence of relevant keywords across company description and industry fields. US figures are reported independently; NYC totals in national comparisons reflect the NYC dataset. All figures are in USD.